We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Eosinophilic granulomatosis with polyangiitis (EGPA, previously named Churg– Strauss syndrome) is a form of necrotizing vasculitis occurring in patients with asthma and eosinophilia. Clinical manifestations are ranging from general symptoms like fever, arthralgias, myalgias and loss of weight, to involvement of virtually any organ system in the body. Nervous system involvement is usual and mainly concerns the peripheral nerves. Mononevritis multiplex is the most frequent finding, followed by peripheral neuropathy. Central nervous system is affected in almost 5% of patients. Ischemic stroke is a relatively rare complication of the disease. Several possible underlying mechanisms of stroke have been proposed: cardioembolism, vasculitis and/or direct eosinophilic infiltration. Given the rarity and the detrimental impact in quality of life and mortality, treatment in EGPA patients with stroke should be more aggressive in order to achieve clinical remission as quickly as possible. The mainstay of treatment is the combination of corticosteroids and immunosuppressants
Lyme disease, the multisystem infectious disease caused by the tick-borne spirochete Borrelia burgdorferi, readily invades the central nervous system (CNS) and, in up to 15% of patients, causes symptomatic meningitis or involvement of the cranial or spinal nerves. The clinical evidence supporting an association between B. burgdorferi infection and cerebral vasculitis or stroke is tenuous at best. Unfortunately, parenchymal brain disease has not been reported in any animal model. Peripheral nerve disease occurs fairly commonly both in infected patients and in experimentally infected rhesus macaque monkeys. Although in both humans and monkeys this is a patchy multifocal disease (mononeuritis multiplex), with perivascular inflammatory infiltrates evident in biopsied nerves, in neither has there ever been evidence of a true vasculitis or significant vasculopathy. Thus, although neurosyphilis has been known for many years to cause vascular inflammation and damage, to date there is little proof that this occurs in Lyme disease.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.